AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca has been granted FDA approval for its once-weekly diabetes medicine Bydureon (exenatide) to treat children (aged 10-18) with type-2 diabetes. The drug, an injectable suspension, aims to lower blood sugar rates. The approval is based on a late-stage study...
NDMA Detected in Dangerous Amounts in Metformin by FDA

NDMA Detected in Dangerous Amounts in Metformin by FDA

Marksans Pharma and Sun Biopharmaceuticals Industries are facilitating recalls through the FDA of their drug Metformin as a result of high NDMA (N-nitrosodimethylamine) it contains. The FDA released a comprehensive list of Metformin products being recalled. It is...
Interviewing Dr. George King, Chief Scientific Officer and the Founder / Director of Asian American Diabetes Initiative (AADI) at the Joslin Diabetes Center, affiliated with Harvard Medical School

Interviewing Dr. George King, Chief Scientific Officer and the Founder / Director of Asian American Diabetes Initiative (AADI) at the Joslin Diabetes Center, affiliated with Harvard Medical School

CSOFT Health Sciences is interviewing Dr. George King, MD at Harvard Medical School’s Joslin Diabetes Center. As the Chief Scientific Officer, a Senior Vice President, and the Founder and Director of the Asian American Diabetes Initiative (AADI), Dr. King is well...